PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

If you're just tuning into baseball again with spring training starting up, congratulations. You've missed a lot. Fortunately, Scott White and Chris Towers have been analyzing all the consequential ...